Patty Malone, MBA, BS, MT ASCP), CTBS, is the Dayton Director of Quality/Regulatory Affairs Director for Solvita, headquartered in Dayton, Ohio.  Patty has a sincere passion for and commitment to the gift of human tissue and the assurance of quality, safety and availability of cells and tissue grafts.  After earning a Bachelor of Science degree in Medical Technology from Wright State University in 1987, Patty began her career in a clinical Microbiology Laboratory.  She began my career at Solvita, formerly Community Blood Center/Community Tissue Services, in the HLA Laboratory in June 1990.  She held a Medical Technology position in the Stem Cell Laboratory and subsequently became the Supervisor of both Stem Cells, Hematology, and Microbiology before moving to the Quality Assurance department in 1996 and subsequently becoming the Director 1998.  Patty earned an MBA from the University of Phoenix in 2019 and also holds a CTBS certification.  She has been an active member of AATB for many years and is currently the Secretary of the Accredited Tissue Banks Council and Vice Chair of the Standards Committee. She serves on the AATB Tissue Policy Group (TPG) and is a member of the TPG Quality/Regulatory Workgroup.

Melissa has 20+ years of experience in medical device, combination product, and human tissue new product development research, engineering, and commercialization. She has experience in Quality System design, implementation, maintenance, and compliance. Melissa has held Quality leadership positions serving as the Management Representative, Head of Quality and official FDA correspondent for prescription eye-glass lens manufacturer QSpex Technologies, Inc., and Chemence Medical Products, Inc, a global manufacturer of adhesive-based Class II medical devices for would closure. During an 11-year tenure with Kimberly-Clark Health Care, Melissa held positions in Regulatory Affairs, Product Development, and Process Engineering. In addition to Quality Systems expertise, Melissa is skilled at developing comprehensive regulatory strategies to support new product development, including pre-market approval requirements for U.S. and E.U. She is a member of the Regulatory Affairs Professional Society (RAPS) and holds an active RAC certification. Melissa holds a B.S. degree in Biological Sciences from the University of Georgia and an MS Degree from the University of Georgia School of Pharmacy in Biomedical and Pharmaceutical Regulatory Affairs. Melissa is a founding member and currently serves as the Chief Quality and Regulatory Officer for StimLabs, LLC based in Roswell, Georgia. In her current role, Melissa is responsible for all aspects of Quality and Regulatory Affairs for StimLabs including Quality Assurance, Quality Control, Quality Engineering, Quality Management Systems, Donor Services, and global regulatory affairs. Melissa is a member of the AATB Quality Counsel and has been serving as a member of the AATB program committee for the last three years and is the chair of the committee this year. In collaboration with AATB council membership and AATB Liaisons, Melissa was responsible for development of the agenda and speaker content for this year’s meeting.

Andrew Vogt joined Hart Health Strategies in September 2022 after more than eight years of combined experience lobbying and working in the U.S. Senate. Prior to joining the Hart Health team, in April 2021, Andrew founded Andrew Vogt Strategies LLC to help businesses and nonprofit organizations more effectively navigate Congress and the federal government.

Andrew's time on Capitol Hill included more than four years as a Health Professional Staff member for the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP). In that role, he planned more than 20 hearings and drafted or negotiated approximately 50 health policy provisions that were signed into law with bipartisan support.

Among the significant laws Andrew worked on are policies related to maternal health, childhood cancer, substance use disorders, regenerative medicine, the healthcare workforce, and community health centers. His proudest achievement was leading the Senate's work on the SUPPORT for Patients and Communities Act (P.L. 115-271), the 2018 "landmark" legislation to confront the opioid and substance use disorder crisis.